New chemo schedule aims to ease harsh side effects for cancer patients
NCT ID NCT06648785
Summary
This study is testing if changing the timing of two common chemotherapy drugs (capecitabine and oxaliplatin) causes fewer and less severe side effects for people with gastrointestinal cancers. The goal is to see if this modified schedule is easier for patients to tolerate than the standard treatment plans. Researchers will measure side effects like nerve pain, blood cell counts, and treatment delays in about 20 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GI CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Vermont
Burlington, Vermont, 05401, United States
-
University of Vermont Medical Center
Burlington, Vermont, 05401, United States
Conditions
Explore the condition pages connected to this study.